FMC Corporation reports first quarter 2026 results above guidance with Adjusted EBITDA above high end of range, reaffirms full-year outlook
Rhea-AI Summary
FMC (NYSE:FMC) reported Q1 2026 revenue of $759M (down 4% vs. Q1 2025) and adjusted EBITDA of $72M. GAAP net loss was $281M and GAAP loss per diluted share was $2.25; adjusted loss per share was $0.23. Sales excluding India were $762M. The company reaffirmed full‑year 2026 guidance: revenue excl. India of $3.60B–$3.80B, adjusted EBITDA of $670M–$730M, adjusted EPS of $1.63–$1.89, and free cash flow of -$65M to $65M. Board‑authorized strategic alternatives review is ongoing.
Positive
- Q1 adjusted EBITDA of $72M
- Sales excluding India of $762M (above guidance midpoint)
- Full‑year 2026 guidance reaffirmed: revenue excl. India $3.60B–$3.80B
- New active ingredient sales expected $300M–$400M for 2026
Negative
- Q1 consolidated GAAP net loss of $281M
- Q1 adjusted EBITDA down 40% vs. prior year
- Full‑year adjusted EBITDA guidance midpoint down 17% vs. 2025
- Adjusted EPS guidance midpoint down 41% vs. 2025
- Q1 cash from operations negative $601M; free cash flow negative $628M
News Market Reaction – FMC
In the Apr 30 session, FMC gained 4.98%, reflecting a moderate positive market reaction. Argus tracked a peak move of +6.9% during that session. Our momentum scanner triggered 14 alerts that day, indicating notable trading interest and price volatility.
Data tracked by StockTitan Argus on the day of publication.
Key Figures
Previous Earnings Reports
| Date | Event | Sentiment | 24h Move | Catalyst |
|---|---|---|---|---|
| Oct 29 | Q3 2025 earnings | Negative | -46.5% | Large India-related charges, net loss, lowered full-year guidance and dividend cut. |
| Jul 30 | Q2 2025 earnings | Positive | -5.5% | Revenue and adjusted earnings growth with guidance maintained and India divest plan. |
| Apr 30 | Q1 2025 earnings | Negative | -8.3% | Double-digit revenue decline and lower adjusted EPS despite reaffirmed 2025 outlook. |
| Jul 31 | Q2 2024 earnings | Positive | +10.3% | Revenue, adjusted EBITDA and EPS growth with outlook calling for stronger H2 2024. |
| May 06 | Q1 2024 earnings | Positive | +9.5% | Results at high end of guidance and maintained full-year revenue and EBITDA outlook. |
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
Earnings releases have averaged a -8.13% move over the last five events, with one notable divergence where positive results met a negative reaction.
Over the last several earnings cycles, FMC has moved from higher revenue and adjusted EPS levels in 2024 toward weaker top-line and profitability metrics in 2025, including large India-related charges and reduced guidance. Multiple updates emphasized maintaining or trimming outlooks and prioritizing debt reduction. Price reactions to earnings were often negative, especially around India charges. Today’s Q1 2026 results, which come in above guidance but with year-over-year declines and a reaffirmed outlook, follow this pattern of earnings acting as key sentiment catalysts.
AI-generated analysis. How Rhea-AI works. Not financial advice.
Company continues to advance operational priorities and explore strategic options in parallel
First Quarter 2026 Highlights
- Revenue of
$759 million - Revenue excluding
India 1 of$762 million India ) - Organic revenue2 for the period declined 9 percent
- Revenue excluding
- Consolidated GAAP net loss of
$281 million $266 million - Adjusted EBITDA of
$72 million - Consolidated GAAP loss of
$2.25 $2.13 - Adjusted loss per diluted share of
$0.23 41 cents versus Q1 2025
Maintains 2026 Full-Year Outlook1
- Revenue excluding
India of$3.60 billion $3.80 billion - Excluding 2025 India contributions, the 2026 outlook represents a decline at the midpoint of 3 percent
- Adjusted EBITDA of
$670 million $730 million - Adjusted earnings per diluted share of
$1.63 $1.89 - Free cash flow of negative
$65 million $65 million $165 million
FMC Revenue | Q1 2026 |
Total Revenue Change (GAAP) | (4) % |
Total Revenue Change (ex- | (4) % |
Less: 2025 revenue for | (5) % |
Like-for-Like Revenue Change (Non-GAAP) | 1 % |
First quarter sales of
FMC Regional Revenue ($M) | Q1 2026 | Q1 2025 |
EMEA | ||
2026 | — | |
Total Revenue (GAAP) |
Note: Regional results ex. |
GAAP net loss in the first quarter declined
On a GAAP basis, cash from operations was negative
Strategy Update
FMC is making strong progress on its 2026 operational priorities, which are strengthening the balance sheet through targeted debt reduction of approximately
Full Year Outlook1
The company reaffirms its full-year 2026 revenue, Adjusted EBITDA, Adjusted EPS and free cash flow guidance ranges. Full year 2026 revenue guidance1 is
Adjusted EBITDA is expected to be
Second Quarter and H2 Outlook1
Second quarter revenue is expected to be in the range of
The midpoint of first-half guidance implies a second-half sales increase of 1 percent versus prior year. Price is expected to be a mid-single digit headwind, driven by competitive market conditions for core portfolio products and pricing actions to support the branded Rynaxypyr® active strategy. Lower price and a minor FX headwind are expected to be more than offset by volume growth, driven primarily by increased sales of products with new active ingredients.
Second-half Adjusted EBITDA is expected to decrease 6 percent as lower price and a minor FX headwind are partially offset by higher volume and favorable costs. Second-half Adjusted EPS is expected to decline 15 percent compared to second half 2025, due to lower Adjusted EBITDA, higher tax, and higher interest expense.
Full-Year 2026 | Q2 2025 | First-Half | Second-Half | |
Revenue Excl. | ||||
Growth at midpoint | (5) % | (17) % | (11) % | 1 % |
Adjusted | ||||
Growth at midpoint | (17) % | (32) % | (35) % | (6) % |
Adjusted | ||||
Growth at midpoint | (41) % | (70) % | (102) % | (15) % |
^ EPS estimates assume 125.9 million diluted shares for full year, Q2 and H2; 125.3 million diluted shares for H1. |
*Percentages are calculated using whole numbers. Minor differences may exist due to rounding. |
Supplemental Information
The company will post supplemental information on the web at https://investors.fmc.com, including its webcast slides for tomorrow's earnings call, definitions of non-GAAP terms and reconciliations of non-GAAP figures to the nearest available GAAP term.
Always read and follow all label directions, restrictions and precautions for use. Products listed here may not be registered for sale or use in all states, countries or jurisdictions. FMC and the FMC logo are trademarks of FMC Corporation or an affiliate.
About FMC
FMC Corporation is a global agricultural sciences company dedicated to helping growers produce food, feed, fiber and fuel for an expanding world population while adapting to a changing environment. FMC's innovative crop protection solutions – including biologicals, crop nutrition, digital and precision agriculture – enable growers and crop advisers to address their toughest challenges economically while protecting the environment. FMC is committed to discovering new herbicide, insecticide and fungicide active ingredients, product formulations and pioneering technologies that are consistently better for the planet. Visit fmc.com to learn more and follow us on LinkedIn®.
Statement under the Safe Harbor Provisions of the Private Securities Litigation Reform Act of 1995: FMC and its representatives may from time to time make written or oral statements that are "forward-looking" and provide other than historical information, including statements contained in this press release, in FMC's other filings with the SEC, and in presentations, reports or letters to FMC stockholders.
In some cases, FMC has identified these forward-looking statements by such words or phrases as "outlook", "will likely result," "is confident that," "expect," "expects," "should," "could," "may," "will continue to," "believe," "believes," "anticipates," "predicts," "forecasts," "estimates," "projects," "potential," "intends" or similar expressions identifying "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995, including the negative of those words or phrases. Such forward-looking statements are based on our current views and assumptions regarding future events, future business conditions and the outlook for the company based on currently available information. The forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause actual results to be materially different from any results, levels of activity, performance or achievements expressed or implied by any forward-looking statement. These statements are qualified by reference to the risk factors included in Part I, Item 1A of our Annual Report on Form 10-K for the year ended December 31, 2025 (the "2025 Form 10-K"), the section captioned "Forward-Looking Information" in Part II of the 2025 Form 10-K and to similar risk factors and cautionary statements in all other reports and forms filed with the Securities and Exchange Commission ("SEC"). We wish to caution readers not to place undue reliance on any such forward-looking statements, which speak only as of the date made. Forward-looking statements are qualified in their entirety by the above cautionary statement.
We specifically decline to undertake any obligation, and specifically disclaim any duty, to publicly update or revise any forward-looking statements that have been made to reflect events or circumstances after the date of such statements or to reflect the occurrence of anticipated or unanticipated events, except as may be required by law.
This press release contains certain "non-GAAP financial terms" which are defined on our website www.fmc.com/investors. Such terms include Adjusted EBITDA, Adjusted earnings, free cash flow and organic revenue growth. In addition, we have also provided on our website reconciliations of non-GAAP terms to the most directly comparable GAAP terms.
- Although we provide forecasts for adjusted earnings per share, Adjusted EBITDA, and free cash flow (non-GAAP financial measures), we are not able to forecast the most directly comparable measures calculated and presented in accordance with GAAP. Certain elements of the composition of the GAAP amounts are not predictable, making it impractical for us to forecast. Such elements include, but are not limited to, restructuring, acquisition charges, our
India held for sale business, and discontinued operations. As a result, no GAAP outlook is provided. Starting with the third quarter 2025 guidance, we provide forecasts for revenue excludingIndia (non-GAAP financial measure). We are not able to forecast the GAAP revenue due to potential actions we may take during the held for sale period to prepare the business for a potential buyer and other uncertainties, including customer reaction to the announcement of our intention to sell ourIndia commercial business. In 2026, revenue, Adjusted EBITDA and Adjusted EPS outlooks provided excludeIndia results and variances are calculated versus 2025 results, which includeIndia results in the first half of the year. - Organic revenue growth (non-GAAP) excludes the impact of foreign currency changes and the removal of
India .
FMC CORPORATION | |||
CONSOLIDATED STATEMENTS OF INCOME (LOSS) | |||
(Unaudited) | |||
Three Months Ended March 31, | |||
(In millions, except per share amounts) | 2026 | 2025 | |
Revenue | $ 758.6 | $ 791.4 | |
Costs of sales and services | 512.0 | 474.7 | |
Gross margin | $ 246.6 | $ 316.7 | |
Selling, general and administrative expenses | 185.1 | 172.0 | |
Research and development expenses | 65.5 | 68.7 | |
Restructuring and other charges (income) | 77.0 | 17.8 | |
Total costs and expenses | $ 839.6 | $ 733.2 | |
Income from continuing operations before non-operating pension, postretirement, and | $ (81.0) | $ 58.2 | |
Non-operating pension, postretirement, and other charges (income) | 3.4 | 3.2 | |
Interest expense, net | 64.8 | 50.1 | |
Income (loss) from continuing operations before income taxes | $ (149.2) | $ 4.9 | |
Provision (benefit) for income taxes | 112.1 | 13.5 | |
Income (loss) from continuing operations | $ (261.3) | $ (8.6) | |
Discontinued operations, net of income taxes | (19.9) | (7.0) | |
Net income (loss) | $ (281.2) | $ (15.6) | |
Less: Net income (loss) attributable to noncontrolling interests | 0.1 | (0.1) | |
Net income (loss) attributable to FMC stockholders | $ (281.3) | $ (15.5) | |
Amounts attributable to FMC stockholders: | |||
Income (loss) from continuing operations, net of tax | $ (261.4) | $ (8.5) | |
Discontinued operations, net of tax | (19.9) | (7.0) | |
Net income (loss) | $ (281.3) | $ (15.5) | |
Basic earnings (loss) per common share attributable to FMC stockholders: | |||
Continuing operations | $ (2.09) | $ (0.06) | |
Discontinued operations | (0.16) | (0.06) | |
Basic earnings per common share | $ (2.25) | $ (0.12) | |
Average number of shares outstanding used in basic earnings per share computations | 125.3 | 125.1 | |
Diluted earnings (loss) per common share attributable to FMC stockholders: | |||
Continuing operations | $ (2.09) | $ (0.06) | |
Discontinued operations | (0.16) | (0.06) | |
Diluted earnings per common share | $ (2.25) | $ (0.12) | |
Average number of shares outstanding used in diluted earnings per share computations | 125.3 | 125.1 | |
Other Data: | |||
Capital additions and other investing activities | $ 15.8 | $ 37.4 | |
Depreciation and amortization expense | $ 42.0 | $ 43.7 | |
FMC CORPORATION | |||
RECONCILIATION OF NON-GAAP FINANCIAL MEASURES | |||
RECONCILIATION OF NET INCOME (LOSS) ATTRIBUTABLE TO FMC STOCKHOLDERS (GAAP) TO | |||
(Unaudited) | |||
Three Months Ended March 31, | |||
(In millions, except per share amounts) | 2026 | 2025 | |
Net income (loss) attributable to FMC stockholders (GAAP) | $ (281.3) | $ (15.5) | |
Corporate special charges (income): | |||
Restructuring and other charges (income) (a) | 94.7 | 17.8 | |
Non-operating pension, postretirement, and other charges (income) (b) | 3.4 | 3.2 | |
16.4 | — | ||
Income tax expense (benefit) on Corporate special charges (income) (d) | (18.3) | (4.4) | |
Discontinued operations attributable to FMC stockholders, net of income taxes (e) | 19.9 | 7.0 | |
Tax adjustment (f) | 136.3 | 14.3 | |
Adjusted after-tax earnings (loss) from continuing operations attributable to FMC | $ (28.9) | $ 22.4 | |
Diluted earnings (loss) per common share (GAAP) | $ (2.25) | $ (0.12) | |
Corporate special charges (income) per diluted share, before tax: | |||
Restructuring and other charges (income) | 0.76 | 0.14 | |
Non-operating pension, postretirement, and other charges (income) | 0.03 | 0.03 | |
0.13 | — | ||
Income tax expense (benefit) on Corporate special charges (income), per diluted share | (0.15) | (0.04) | |
Discontinued operations attributable to FMC stockholders, net of income taxes per diluted share | 0.16 | 0.06 | |
Tax adjustments per diluted share | 1.09 | 0.11 | |
Diluted adjusted after-tax earnings (loss) from continuing operations per share, | $ (0.23) | $ 0.18 | |
Average number of shares outstanding used in diluted adjusted after-tax earnings (loss) from | 125.3 | 125.5 | |
(1) | Referred to as Adjusted earnings. The Company believes that Adjusted earnings, a non-GAAP financial measure, and its presentation on a per share basis provides useful information about the Company's operating results to management, investors, and securities analysts. Adjusted earnings excludes the effects of corporate special charges, the | ||||
(a) | Three Months Ended March 31, 2026: | ||||
Restructuring and other charges (income) includes restructuring charges of | |||||
Three Months Ended March 31, 2025: | |||||
Restructuring and other charges (income) includes restructuring charges of | |||||
(b) | Our non-operating pension, postretirement and other charges (income) includes those costs (benefits) related to interest, expected return on plan assets, amortized actuarial gains and losses and the impacts of any plan curtailments or settlements. These are excluded from our Adjusted earnings and are primarily related to changes in pension plan assets and liabilities which are tied to financial market performance and we consider these costs to be outside our operational performance. We continue to include the service cost and amortization of prior service cost in our Adjusted earnings results noted above. These elements reflect the current year operating costs to our businesses for the employment benefits provided to active employees. | ||||
(c) | In July 2025, the Board of Directors approved a plan to divest the Company's commercial business in | ||||
Three Months Ended March 31, | Affected Line Item in the Consolidated | |||
(In millions) | 2026 | 2025 | ||
Operating results | $ 34.1 | $ — | Revenue, Cost of sales and services, and | |
Asset impairment | (20.4) | — | Restructuring and other charges (income) | |
Third party provider costs | 2.7 | — | Restructuring and other charges (income) | |
$ 16.4 | $ — | |||
(d) | The income tax expense (benefit) on Corporate special charges (income) is determined using the applicable rates in the taxing jurisdictions in which the corporate special charge or income occurred and includes both current and deferred income tax expense (benefit) based on the nature of the non-GAAP performance measure. |
(e) | Discontinued operations includes provisions, net of recoveries, for environmental liabilities and legal reserves and expenses related to previously discontinued operations and retained liabilities. |
(f) | We exclude the GAAP tax provision, including discrete items, from the non-GAAP measure of income, and include a non-GAAP tax provision based upon the projected annual non-GAAP effective tax rate. The GAAP tax provision includes certain discrete tax items including, but are not limited to: income tax expenses or benefits that are not related to continuing operating results in the current year; tax adjustments associated with fluctuations in foreign currency remeasurement of certain foreign operations; certain changes in estimates of tax matters related to prior fiscal years; certain changes in the realizability of deferred tax assets and related interim accounting impacts; and changes in tax law. In 2024 and 2023, we recorded significant deferred tax assets due to various tax incentives granted to the Company's Swiss subsidiaries (the "Swiss Tax Incentives"). The initial recognition of these Swiss Tax Incentives did not impact our adjusted non-GAAP effective tax rate but will be considered annually as we realize the benefits. Management believes excluding these discrete tax items, as well as the impacts of the Swiss Tax Incentives annually as the related benefits are realized, assists investors and securities analysts in understanding the tax provision and the effective tax rate related to continuing operating results thereby providing investors with useful supplemental information about FMC's operational performance. |
Three Months Ended March 31, | |||
(In millions) | 2026 | 2025 | |
Tax adjustments: | |||
Revisions to valuation allowances of historical deferred tax assets (i) | $ 124.7 | $ (1.2) | |
Net impact of | (5.5) | 2.8 | |
Foreign currency remeasurement and other discrete items | 17.1 | 12.7 | |
Total non-GAAP tax adjustments | $ 136.3 | $ 14.3 | |
(i) | As a result of changes in global earnings mix and ongoing tax planning implemented in March 2026, we reevaluated the realizability of our historical deferred tax assets and recorded an increase to our valuation allowance in | ||||
RECONCILIATION OF NET INCOME (LOSS) (GAAP) TO ADJUSTED EARNINGS FROM CONTINUING | |||
(Unaudited) | |||
Three Months Ended March 31, | |||
(In millions) | 2026 | 2025 | |
Net income (loss) (GAAP) | $ (281.2) | $ (15.6) | |
Restructuring and other charges (income) (1) | 94.7 | 17.8 | |
Non-operating pension, postretirement, and other charges (income) | 3.4 | 3.2 | |
16.4 | — | ||
Discontinued operations, net of income taxes | 19.9 | 7.0 | |
Interest expense, net | 64.8 | 50.1 | |
Depreciation and amortization | 42.0 | 43.7 | |
Provision (benefit) for income taxes | 112.1 | 13.5 | |
Adjusted earnings from continuing operations, before interest, income taxes, depreciation | $ 72.1 | $ 119.7 | |
(1) | In the reconciliation above, favorable adjustments recorded in connection with the | ||||
(2) | Beginning with the third quarter of 2025, we excluded the operating results of the | ||||
(3) | Referred to as Adjusted EBITDA. Defined as operating profit excluding restructuring and other charges (income), depreciation and amortization expense, and the | ||||
RECONCILIATION OF CASH PROVIDED (REQUIRED) BY OPERATING ACTIVITIES OF CONTINUING | |||
(Unaudited) | |||
Three Months Ended March 31, | |||
(In millions) | 2026 | 2025 | |
Cash provided (required) by operating activities of continuing operations (GAAP) (1) | $ (600.9) | $ (545.0) | |
Capital expenditures | (16.6) | (31.6) | |
Other investing activities | 0.8 | (5.8) | |
Capital additions and other investing activities | $ (15.8) | $ (37.4) | |
Cash provided (required) by operating activities of discontinued operations | (15.7) | (13.3) | |
Divestiture transaction costs (2) | 4.3 | — | |
Free cash flow (non-GAAP) (3) | $ (628.1) | $ (595.7) | |
(1) | The three months ended March 31, 2026 includes cash payments of | ||||
(2) | Represents third party provider costs associated with the expected sale of our | ||||
(3) | Free cash flow is defined as cash provided (required) by operating activities of continuing operations (GAAP) adjusted for spending for capital additions and other investing activities as well as cash provided (required) by discontinued operations and divestiture transaction costs associated with the sale of our GSS business. We believe that this non-GAAP financial measure provides a useful basis for investors and securities analysts to evaluate the cash generated by routine business operations, including to assess our ability to repay debt, fund acquisitions and return capital to shareholders through share repurchases and dividends. Our use of free cash flow has limitations as an analytical tool and should not be considered in isolation or as a substitute for an analysis of our results under | ||||
RECONCILIATION OF REVENUE (GAAP) | |||
TO REVENUE EXCLUDING | |||
(Unaudited) | |||
Three Months Ended March 31, | |||
(In millions) | 2026 | 2025 | |
Revenue (GAAP) | $ 758.6 | $ 791.4 | |
Less: Revenue from | (3.8) | — | |
Revenue excluding | $ 762.4 | $ 791.4 | |
(1) | Beginning with the third quarter of 2025, revenue from the | ||||
(2) | Although the | ||||
RECONCILIATION OF REVENUE CHANGE (GAAP) TO | |
(Unaudited) | |
Three Months Ended March 31, 2026 vs. 2025 | |
Total revenue (GAAP) change | (4) % |
Less: Revenue for | — % |
Revenue excluding | (4) % |
Less: Foreign currency impact | 5 % |
Organic revenue (non-GAAP) change (2) | (9) % |
(1) | Beginning with the third quarter of 2025, revenue from the | ||||
(2) | We believe organic revenue growth (non-GAAP) provides management and investors with useful supplemental information regarding our ongoing revenue performance and trends by presenting revenue growth excluding the impact of fluctuations in foreign exchange rates and the | ||||
RECONCILIATION OF NET INCOME (LOSS) ATTRIBUTABLE TO | |||
FMC STOCKHOLDERS (GAAP) TO RETURN ON INVESTED CAPITAL ("ROIC") | |||
NUMERATOR (NON-GAAP) AND ADJUSTED ROIC (USING NON-GAAP NUMERATOR) (1) | |||
(Unaudited) | |||
Twelve Months Ended | |||
(In millions, except percentages) | March 31, 2026 | ||
Net income (loss) attributable to FMC stockholders (GAAP) | $ (2,504.7) | ||
Interest expense, net, net of income taxes | 218.7 | ||
Corporate special charges (income) | 1,871.5 | ||
538.1 | |||
Income tax expense (benefit) on Corporate special charges (income) | (172.0) | ||
Discontinued operations attributable to FMC stockholders, net of income | 49.5 | ||
Tax adjustments | 538.3 | ||
ROIC numerator (non-GAAP) | $ 539.4 | ||
March 31, 2026 | March 31, 2025 | ||
Total debt | $ 4,533.6 | $ 4,003.5 | |
Total FMC stockholders' equity | 1,822.1 | 4,382.0 | |
Total debt and FMC stockholders' equity (GAAP) | $ 6,355.7 | $ 8,385.5 | |
ROIC denominator (2 yr average total debt and FMC stockholders' equity) | $ 7,370.6 | ||
ROIC (using Net income (loss) attributable to FMC stockholders (GAAP) | (33.98) % | ||
Adjusted ROIC (using non-GAAP numerator) (1) | 7.32 % | ||
(1) | We believe Adjusted ROIC (non-GAAP) provides management and investors with useful supplemental information regarding our utilization of capital provided by both equity and debt as well as our working capital and free cash flow management. Additionally, vesting of certain restricted stock awards granted to officers is connected to Adjusted ROIC as a performance metric. | ||||
FMC CORPORATION | |||
CONDENSED CONSOLIDATED BALANCE SHEETS | |||
(Unaudited) | |||
(In millions) | March 31, 2026 | December 31, 2025 | |
Cash and cash equivalents | $ 390.9 | $ 584.5 | |
Trade receivables, net of allowance of | 2,244.8 | 2,062.0 | |
Inventories | 1,242.6 | 1,219.6 | |
Prepaid and other current assets | 533.7 | 481.2 | |
Assets held for sale (1) | 492.9 | 611.7 | |
Total current assets | $ 4,904.9 | $ 4,959.0 | |
Property, plant and equipment, net | 627.5 | 707.4 | |
Other intangibles, net | 2,333.5 | 2,361.8 | |
Deferred income taxes | 1,096.0 | 1,215.6 | |
Other long-term assets | 457.6 | 443.4 | |
Total assets | $ 9,419.5 | $ 9,687.2 | |
Short-term debt and current portion of long-term debt | $ 1,763.0 | $ 1,305.1 | |
Accounts payable, trade and other | 634.1 | 771.0 | |
Advanced payments from customers | 196.3 | 453.1 | |
Accrued and other liabilities | 625.5 | 574.0 | |
Accrued customer rebates | 480.0 | 417.4 | |
Guarantees of vendor financing | 37.0 | 45.7 | |
Accrued pensions and other postretirement benefits, current | 3.3 | 3.3 | |
Income taxes | 26.6 | 24.0 | |
Liabilities held for sale (1) | 47.5 | 161.7 | |
Total current liabilities | $ 3,813.3 | $ 3,755.3 | |
Long-term debt, less current portion | $ 2,770.6 | $ 2,769.8 | |
Long-term liabilities | 985.7 | 1,063.2 | |
Equity | 1,849.9 | 2,098.9 | |
Total liabilities and equity | $ 9,419.5 | $ 9,687.2 | |
(1) | The carrying value of the | ||||
FMC CORPORATION | |||
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS | |||
(Unaudited) | |||
Three Months Ended March 31, | |||
(In millions) | 2026 | 2025 | |
Cash provided (required) by operating activities of continuing operations | $ (600.9) | $ (545.0) | |
Cash provided (required) by operating activities of discontinued operations | (15.7) | (13.3) | |
Cash provided (required) by investing activities of continuing operations | (16.2) | (38.0) | |
Cash provided (required) by financing activities of continuing operations | 442.3 | 552.1 | |
Effect of exchange rate changes on cash | (3.1) | 2.2 | |
Increase (decrease) in cash and cash equivalents | $ (193.6) | $ (42.0) | |
Cash and cash equivalents, beginning of period | $ 584.5 | $ 357.3 | |
Cash and cash equivalents, end of period | $ 390.9 | $ 315.3 | |
View original content to download multimedia:https://www.prnewswire.com/news-releases/fmc-corporation-reports-first-quarter-2026-results-above-guidance-with-adjusted-ebitda-above-high-end-of-range-reaffirms-full-year-outlook-302757928.html
SOURCE FMC Corporation